Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Vascular and metabolic diseases cause half of total mortality in Europe. New prognostic markers would provide a valuable tool to improve outcome. First evidence supports the usefulness of plasma lipid species as easily accessible markers for certain diseases. Here we analyzed association of plasma lipid species with mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Plasma lipid species were quantified by electrospray ionization tandem mass spectrometry and Cox proportional hazards regression was applied to assess their association with total and cardiovascular mortality. Overall no differences were detected between total and cardiovascular mortality. Highly polyunsaturated phosphatidylcholine species together with lysophosphatidylcholine species and long chain saturated sphingomyelin and ceramide species seem to be associated with a protective effect. The predominantly circulating phosphatidylcholine-based as well as phosphatidylethanolamine-based ether species and phosphatidylethanolamine species were positively associated with total and cardiovascular mortality. Saturated and monounsaturated phosphatidylcholine species, especially phosphatidylcholine 32∶0 (most probably dipalmitoyl-phosphatidylcholine) and palmitate containing sphingomyelin and ceramide species showed together with 24∶1 containing sphingomyelin and ceramide species strongest positive association with mortality. A quotient of the sums of the six most protective species and the six species with the strongest positive mortality association indicated an almost 3-fold increased risk of mortality, which was higher than the hazard ratio for known risk factors in our cohort. Plasma lipid species levels and especially ratios of certain species may be valuable prognostic marker for cardiovascular and total mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673 · cited 1×
“Both, palmitate and stearate, have been shown to induce apoptosis in cultured cells [21–23] and part of cardiomyocyte loss in genesis or progression of heart failure in humans is mediated by apoptosis [24].”
BackgroundLipidomics reveals a remarkable diversity of lipids in human plasma
Quehenberger, O., Armando, A. M., Brown, A. H., Milne, S. B., Myers, D. S., Merrill, A. H., Bandyopadhyay, S., Jones, K. N., Kelly, S., Shaner, R. L., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m009449 · Cited by 1,341 · cited 1×
“These data may serve as base for additional studies to analyze their role in health and disease [3].”
BackgroundFatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142 · cited 2×
“While this appears to be true for some cell types [22,23] other data indicate that Cer is not causal for FA-induced apoptosis [25] but may enhance the effect [25].”
BackgroundGenetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum
Gieger, C., Geistlinger, L., Altmaier, E., Hrabé de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.-W., Wichmann, H.-E., Weinberger, K. M., Adamski, J., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000282 · Cited by 737 · cited 2×
“These FAs are found for example in PC 36:3 and PC 36:4 and the ratio between PC 36:3 and 36:4 is regarded as a good predictor of the FADS1/ D5D activity [13].”
BackgroundA genome-wide perspective of genetic variation in human metabolism
Illig, T., Gieger, C., Zhai, G., Römisch-Margl, W., Wang-Sattler, R., Prehn, C., Altmaier, E., Kastenmüller, G., Kato, B. S., Mewes, H.-W., et al. (2010) · Nature Genetics · doi:10.1038/ng.507 · Cited by 653
When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?
Pewzner-Jung, Y., Ben-Dor, S., & Futerman, A. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600010200 · Cited by 435 · cited 1×
“The FADS cluster is also associated to SM species formation, where FA chain length and desaturation determine substrate specificity for Cer-synthases regulating the FA composition of Cer [17] from which SM is generated.”
BackgroundHan, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429 · cited 1×
“type 1 diabetes [4], non-alcoholic fatty liver disease [5] and that plasma sphingomyelin (SM) and ceramide (Cer) may be used as potential biomarkers for Alzheimers disease [6].”
BackgroundPaumen, M. B., Ishida, Y., Muramatsu, M., Yamamoto, M., & Honjo, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3324 · Cited by 349 · cited 11×
“De novo Cer synthesis shows pronounced specificity for the saturated long chain FAs palmitate (16:0) and stearate (18:0) [20].”
BackgroundInfluentialLeskinen, T., Rinnankoski-Tuikka, R., Rintala, M., Seppänen-Laakso, T., Pöllänen, E., Alen, M., Sipilä, S., Kaprio, J., Kovanen, V., Rahkila, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012609 · Cited by 75 · cited 2×
“This may reflect diet and/or physical activity of the patients, as it was shown that e.g. fish oil supplementation increased the relative amount of PUFA containing phospholipids and tryglycerides [39] and that physical activity leads to higher amounts of PUFA containing TGs [40].”
Background
Cited by
Sphingolipids and their metabolism in physiology and disease
Hannun, Y. A., & Obeid, L. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.107 · Cited by 2,051
Alterations in the gut microbiome and metabolism with coronary artery disease severity
Liu, H., Chen, X., Hu, X., Niu, H., Tian, R., Wang, H., Pang, H., Jiang, L., Qiu, B., Chen, X., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0683-9 · Cited by 372
Mikhalkova, D., Holman, S. R., Jiang, H., Saghir, M., Novak, E., Coggan, A. R., O'Connor, R., Bashir, A., Jamal, A., Ory, D. S., et al. (2018) · Obesity · doi:10.1002/oby.22038 · Cited by 121
“There are some indications that certain ceramides, and possibly sphingomyelins, may be associated with favorable outcomes and that others may be associated with adverse outcomes in patients referred for cardiac catheterization (36).”
Narath, S. H., Mautner, S. I., Svehlikova, E., Schultes, B., Pieber, T. R., Sinner, F. M., Gander, E., Libiseller, G., Schimek, M. G., Sourij, H., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161425 · Cited by 65
“For other PCs such as PC36:5 we found a V-pattern or a steady increase (PC40:7), both metabolites have been shown to be inversely associated with coronary artery disease and mortality [69].”
BackgroundHuang, J., Huth, C., Covic, M., Troll, M., Adam, J., Zukunft, S., Prehn, C., Wang, L., Nano, J., Scheerer, M. F., et al. (2020) · Diabetes · doi:10.2337/db20-0586 · Cited by 60
Metadata
- Authors
- Sigruener, A., Kleber, M. E., Heimerl, S., Liebisch, G., Schmitz, G., & Maerz, W.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-01-17
- Volume
- 9
- Issue
- 1
- Pages
- e85724
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2029969585
- Cited by
- 155
- References
- 9
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. https://app.cochat.ai/papers/10.1371/journal.pone.0085724
- The paper
- Sigruener, A., Kleber, M. E., Heimerl, S., Liebisch, G., Schmitz, G., & Maerz, W. (2014). Glycerophospholipid and Sphingolipid Species and Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. PLoS ONE. https://doi.org/10.1371/journal.pone.0085724
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.